Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 109-120 of 2,031
Drug study icon
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.

Multiple locations, including Moorpark
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, Australia, Canada, ...
Sponsor
Eli Lilly and Company
Condition
Depression
Drug study icon
RecruitingNCT07227454

Esketamine for depression

This study is recruiting in the United States, in Brazil, in Hungary, .... It is testing esketamine for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 12 Years to 17 Years
Countries
United States, Brazil, Hungary, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Device study icon
RecruitingNCT06968390

Accelerated TMS for Perinatal Depression

This study is looking at whether a digital support tool can help people with Perinatal Depression, Post Partum Depression, or depression. Participants receive a study treatment and complete follow-up visits and assessments.

In Boston
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 55 Years
Countries
United States
Sponsor
Brigham and Women's Hospital
Condition
Depression
Behavioral study icon
RecruitingNCT05583747

E-field Guided iTBS for Treatment Resistant Depression

This study is looking at whether iTBS can help people with depression. Participants take part in iTBS and complete follow-up assessments.

In Toronto
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Drug study icon
RecruitingNCT07146503

Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression

This observational study is following people with depression or anxiety to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Genova
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyDrugFrom 18 Years to 74 Years
Countries
Italy
Sponsor
Riccardo Guglielmo
Condition
Depression, Anxiety
Behavioral study icon
RecruitingISRCTN11790528

Functional imaging-based targeting of transcranial magnetic stimulation for treatment-resistant depression

This study is looking at a support or therapy approach for people with depression, resistant to at least two antidepressants or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.

In Finland
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 67 Years
Countries
Finland
Sponsor
Hospital District of Helsinki and Uusimaa
Condition
Depression
Device study icon
RecruitingNCT05813093

Interleaved TMS-fMRI in Ultra-treatment Resistant Depression

This observational study is following people with depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Toronto
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 20 Years to 65 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.